Posted by Warm Southern Breeze on Saturday, May 11, 2013
Thanks to a newly introduced aspect of ObamaCare, hospitals are now mandated to publicly show how much they charge for procedures.
Aren’t you glad?
I mean really… who goes to a grocery store or gas station and doesn’t know how much they’ll pay?
Part of market-based competition includes Read the rest of this entry »
Posted in - Business... None of yours, - Do you feel like we do, Dr. Who?, - My Hometown is the sweetest place I know | Tagged: Alabama, Antiques and Collectibles, breathing, business, cheap, Chronic Obstructive Pulmonary Disease, comparison, COPD, cost, cost comparison, cost effective, Crestwood Medical Center, Decatur, DO, doctors, expense, expnsive, fainting, healing, health, Health care reform, healthcare, heart, high blood pressure, hospital, HTN, Huntsville, Huntsville Alabama, Huntsville Hospital, Huntsville Hospital System, hypertension, inexpensive, infection, lungs, MD, Medflight, north Alabama, nurses, Ontario, pass out, passed out, Patient Protection and Affordable Care Act, physicians, RN, shopping, syncope, treatment, uncomplicated, United States, Urinary Tract Infection, UTI, WHNT-TV | 4 Comments »
Posted by Warm Southern Breeze on Saturday, July 28, 2012
If you’re presently taking the “blood thinner” medications in this news item, it may be in the best interest of your health, and life, to reconsider and stay with warfarin/coumadin.
At least with warfarin/coumadin, we have an antidote, and it has far fewer risks associated with it.
In short, it has evidence for greater safety.
Here’s the long & short of it:
Deaths associated with Warfarin/Coumadin in 2011 = 72
Deaths associated with Praxaxa in 2011 = 542
There was NO OTHER MEDICINE with such a high rate of death associated with death.
Annual Cost of Medicine: Pradaxa & Xarelto = $3,000
Annual Cost of Medicine: Coumadin/Warfarin = $200
You do the math.
Wanna’ be a statistic?
Insight: Top heart doctors fret over new blood thinners
By Ransdell Pierson
NEW YORK | Thu Jun 14, 2012 1:37pm EDT
(Reuters) – For millions of heart patients, a pair of new blood thinners have been heralded as the first replacements in 60 years for warfarin, a pill whose hardships and risks have deterred many from using the stroke-prevention medicine.
A sign is seen at the entrance of an anti-coagulation clinic at the Staten Island University Hospital in Staten Island, New York May 7, 2012. For millions of heart patients, a pair of new blood thinners have been heralded as the first replacements in 60 years for warfarin, a pill whose hardships and risks have deterred many from using the stroke-prevention medicine. Picture taken May 7, 2012. REUTERS/Allison Joyce
But growing complaints of risks and deaths tied to the new crop of drugs have made some top U.S. cardiologists hesitant to prescribe them. Some are proposing a more rigorous monitoring regimen for when they are used.
Most concerns revolve around Pradaxa, a twice daily pill from Boehringer Ingelheim that was approved by the U.S. Food and Drug Administration in October 2010 to prevent strokes in patients with an irregular heartbeat called atrial fibrillation. It was the first new oral treatment for that use since warfarin was introduced in the 1950s.
“The good news is you now have an alternative to warfarin,” said Dr. Alan Jacobson, director of anti-coagulation services at the Veterans Administration (VA) healthcare system in Loma Linda, California. “The bad news is you can kill a patient as easily with the new drug as you could with the old drug” if it is not handled properly.
“The average patient doesn’t understand anything Read the rest of this entry »
Posted in - Do you feel like we do, Dr. Who?, - Read 'em and weep: The Daily News | Tagged: afib, Anticoagulant, atrial fibrillation, Blood, blood thinner, Boehringer Ingelheim, Bristol-Myers Squibb, cardiologist, cardiology, Cedars-Sinai Medical Center, cost, costly, coumadin, Dabigatran, danger, dangerous, deaths, expense, expensive, FDA, Food and Drug Administration, health, healthcare, inexpensive, Johnson, money, Pradaxa, risk, stroke, tested, time tested, true, warfarin, Xarelto | Leave a Comment »